These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27555138)

  • 1. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2.
    Kumakura M; Hara K; Sata T
    J Clin Anesth; 2016 Sep; 33():81-5. PubMed ID: 27555138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
    Saussine M; Massad I; Raczka F; Davy JM; Frapier JM
    Paediatr Anaesth; 2006 Jan; 16(1):63-5. PubMed ID: 16409532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEVOFLURANE AS A CAUSE OF TORSADE DE POINTES IN PATIENT WITH THE LONG QT SYNDROME: Case Report.
    Choromanski DW; Amin S; Zestos MM
    Middle East J Anaesthesiol; 2016 Feb; 23(4):471-4. PubMed ID: 27382818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier.
    Tan VH; Duff H; Kuriachan V; Gerull B
    Heart Lung; 2014; 43(6):541-5. PubMed ID: 25236808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long QT syndrome and anaesthesia].
    Rasche S; Koch T; Hübler M
    Anaesthesist; 2006 Mar; 55(3):229-46. PubMed ID: 16447035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of onset of torsade de pointes in congenital long QT syndrome.
    Viskin S; Alla SR; Barron HV; Heller K; Saxon L; Kitzis I; Hare GF; Wong MJ; Lesh MD; Scheinman MM
    J Am Coll Cardiol; 1996 Nov; 28(5):1262-8. PubMed ID: 8890825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes ventricular tachycardia during, but not necessarily caused by, sevoflurane anesthesia.
    Daley MD; Norman PH
    Anesth Analg; 1998 Oct; 87(4):981; author reply 981-2. PubMed ID: 9768813
    [No Abstract]   [Full Text] [Related]  

  • 9. Torsade de pointes in a patient with acute prolonged QT syndrome and poorly controlled diabetes during sevoflurane anaesthesia.
    Thiruvenkatarajan V; Osborn KD; Van Wijk RM; Euler P; Sethi R; Moodie S; Biradar V
    Anaesth Intensive Care; 2010 May; 38(3):555-9. PubMed ID: 20514968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of anesthesia in children with long QT syndrome.
    Nathan AT; Berkowitz DH; Montenegro LM; Nicolson SC; Vetter VL; Jobes DR
    Anesth Analg; 2011 May; 112(5):1163-8. PubMed ID: 21346158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation.
    Yin C; Zhang P; Yang J; Zhang L
    J Electrocardiol; 2018; 51(1):111-116. PubMed ID: 29037423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes with sevoflurane.
    Whyte SD; Sanatani S; Booker PD
    Paediatr Anaesth; 2006 Nov; 16(11):1199-201; author reply 1201. PubMed ID: 17040316
    [No Abstract]   [Full Text] [Related]  

  • 14. Long QT syndrome with nocturnal cardiac events caused by a KCNH2 missense mutation (G604S).
    Sato A; Chinushi M; Suzuki H; Numano F; Hanyu T; Iijima K; Watanabe H; Furushima H
    Intern Med; 2012; 51(14):1857-60. PubMed ID: 22821100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane and torsade de pointes.
    Deem S
    Anesth Analg; 1998 Oct; 87(4):981-2. PubMed ID: 9768814
    [No Abstract]   [Full Text] [Related]  

  • 16. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications.
    Tan HL; Bardai A; Shimizu W; Moss AJ; Schulze-Bahr E; Noda T; Wilde AA
    Circulation; 2006 Nov; 114(20):2096-103. PubMed ID: 17088455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome.
    Noda T; Shimizu W; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    Eur Heart J; 2004 Dec; 25(23):2149-54. PubMed ID: 15571831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine effectively prevented refractory Torsades de Pointes and ventricular fibrillation in a patient with congenital type 2 long QT syndrome.
    Nakashima R; Takase S; Kai K; Sakamoto K; Tsutsui H
    J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1592-1595. PubMed ID: 35488741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Torsades de pointes induced by sevoflurane].
    Rodríguez-Borregan JC; Buron-Mediavilla FJ; Arnaiz-Arnaiz V; Marco-Moreno JM
    Med Intensiva; 2009; 33(1):55-6. PubMed ID: 19232211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.